Discover 2,423 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,423
Cardiogenic Shock Working Group Registry
for
Cardiogenic Shock
Location: Falls Church VA, Baltimore MD, Philadelphia PA,
Sponsor: Tufts Medical Center
Sex: All
Age: 18+
Code: NCT04682483
Recruiting
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
for
CLL, Chronic Lymphocytic Leukemia, SLL
Location: Bethesda MD, York PA, Pittsburgh PA, New York NY,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06846671
Phase 3, Recruiting
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma,
Location: Bethesda MD, Arlington VA, Silver Spring MD,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07392892
Phase 2, Phase 3, Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
for
Breast Cancer
Location: Bethesda MD, Washington D.C. DC, Arlington VA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07062965
Phase 3, Recruiting
Same-Day Discharge After Nipple-sparing Mastectomy or Skin-sparing Mastectomy With Breast Reconstruction
for
Breast Cancer, Mastectomy; Lymphedema, Same Day Surgery,
Location: Washington DC, Baltimore MD
Sponsor: Georgetown University
Sex: Female
Age: 18+
Code: NCT04596683
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Bethesda MD, Richmond VA, New York NY, Buffalo NY,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT05006716
Phase 1, Phase 2, Recruiting
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
for
Advanced Cancer
Location: Bethesda MD, Fairfax VA, Baltimore MD, Newark DE,
Sponsor: Riboscience, LLC.
Sex: All
Age: 18+
Code: NCT05270213
Phase 1, Recruiting
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
for
Lung Neoplasm
Location: Baltimore MD, Durham NC, Cleveland OH, Boston MA,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT02984761
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Location: Bethesda MD, Philadelphia PA, Indianapolis IN,
Sponsor: CellCentric Ltd.
Sex: All
Age: 18+
Code: NCT04068597
Phase 1, Phase 2, Recruiting
ShuntCheck-Micro-Pumper Pediatric Clinical Outcomes Study
for
Suspected CSF Shunt Obstruction
Location: Washington DC, Baltimore MD, Wilmington DE,
Sponsor: NeuroDx Development
Sex: All
Age: 2 - 29
Code: NCT01881711
Recruiting
Study to Evaluate Tetanizing Burst Therapy in Patients Undergoing ICD Replacement
for
Cardiac Electrophysiology
Location: Baltimore MD
Sponsor: EP Sciences
Sex: All
Age: 18 - 70+
Code: NCT03628911
Recruiting
Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis
for
Chronic Pancreatitis, Chronic Pain
Location: Baltimore MD, Pittsburgh PA, Indianapolis IN
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT04996628
Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for
cGVHD
Location: Baltimore MD, Danville PA, New Brunswick NJ,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT05919511
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
for
Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Location: Baltimore MD, Philadelphia PA, Virginia Beach VA,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT06423911
Phase 3, Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: Bethesda MD, Silver Spring MD, Rockville MD, Clinton MD,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Location: Bethesda MD, Toledo OH, Grand Rapids MI, Orange City FL,